STELARA® (ustekinumab) Has Expanded First-Line Biologic* Access for Your Patients1


Commercial Pharmacy Benefit Manager/Plan
CVS Caremark Advanced Control (Indication-Managed)
First-line biologic access
First-line biologic access
Express Scripts National Basic
First-line biologic access
Express Scripts National Preferred
First-line biologic access
First-line biologic access
First-line biologic access
Federal Employee Plan (FEP)
First-line biologic access
First-line biologic access

Not all plans that cover STELARA® are listed. Coverage relevant to your patients may vary.

*First-line biologic: Brand-name drugs that do not require trial on another biologic product prior to utilization.

Collected on February 2019 and subject to change.

The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this document, the information may not be as current or comprehensive when you view it. Please refer to the applicable plan’s website, or contact the plan for more information about coverage or any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility of Janssen Biotech, Inc.

Reference: 1. Coverage Data Provided by Managed Markets Insight and Technology, LLCTM, a trademark of MMIT, as of February 2019.

A streamlined, all-in-one, web-based solution designed to help start patients on STELARA®

iAssist Provides...

Electronic Prescribing

Prescribe STELARA® electronically in  1 simple transaction

Electronic Prior Authorizations

Real-time ePA capability—improves accuracy and accelerates coverage determination

Janssen Support Within iAssist

Patient Support at Your Fingertips provides online access to Janssen Patient Support Programs

AssistRx is a third-party technology solutions provider. iAssist is an AssistRx online platform to support the processes of prescribing and distributing prescription therapies, and connects patients to the services that support them throughout treatment.


Janssen CarePath

Access support

to help navigate payer processes

Janssen CarePath helps verify insurance coverage for your patients taking STELARA® and provides reimbursement information.

Affordability support

to help your patients start and stay on treatment you prescribe

Janssen CarePath can help you find out what affordability assistance may be available for your patients taking STELARA®.

Treatment support

to help your patients get informed and stay on STELARA®

Janssen CarePath provides additional support to your patients, including patient education, web-based resources, and personalized reminders.

Prescribe STELARA®

Complete the Benefits Investigation and Prescription Form online in the Provider Portal or download the digital form, fill it in online (recommended), and fax to 855-224-5072

Complete Form Online Download Form

Janssen CarePath Savings Program

Eligible commercial patients pay $5 for each injection

Janssen CarePath Savings Program allows eligible patients to save on their out-of-pocket medication costs. Depending on the health insurance plan, savings may apply toward co-pay, co-insurance, or deductible.

  • Eligible patients pay $5 for each injection, with a $20,000 maximum program benefit per calendar year
  • Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement
  • For medication costs only; program does not cover cost to give patients their treatment
  • The Savings Program for STELARA® provides a rebate when used with medical/primary insurance and provides instant savings when used with pharmacy/prescription insurance

See full eligibility requirements at

Janssen Biotech, Inc., the maker of STELARA®, is not liable for unintended or unauthorized use of the STELARA® Mastercard® if it is lost or stolen. The Janssen CarePath Savings Program for STELARA® Prepaid Mastercard is issued by MetaBank®, Member FDIC, pursuant to license by Mastercard International Incorporated. Mastercard is a registered trademark, and the circles design is a trademark of Mastercard International Incorporated. Janssen CarePath Savings Program is not a MetaBank or Mastercard product or service, nor is the optional offer endorsed by them.